Ohio Attorney General Mike DeWine announced today that a rebate agreement that has saved Ohio agencies nearly $400,000 on the cost of naloxone since 2015 has been extended for one year.
The renewed agreement with Amphastar Pharmaceuticals, Inc. will continue to allow non-federal public entities in Ohio to receive a $6 rebate for each Amphastar naloxone syringe purchased until March 2, 2018.